The multidisciplinary team for management of inflammatory bowel diseases

Digestive and Liver Disease

Volumn 40, Issue SUPPL. 2, 2008, Pages

  Ricci, C ^a   Lanzarotto, F ^a   Lanzini, A ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

Inflammatory bowel disease; Multidisciplinary team; Quality of care

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; MERCAPTOPURINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ANTIBODY;

ABDOMINAL RADIOGRAPHY; ARTICLE; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; COOPERATION; CORTICOSTEROID INDUCED OSTEOPOROSIS; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE EXACERBATION; DOCTOR PATIENT RELATION; DRUG HYPERSENSITIVITY; ECHOGRAPHY; ENTERITIS; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH PRACTITIONER; HUMAN; INFECTION SENSITIVITY; INTESTINE SURGERY; LEUKOPENIA; LIFESTYLE MODIFICATION; LIVER DISEASE; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; PANCREATITIS; PATIENT COMPLIANCE; PATIENT COUNSELING; PHYSICIAN ATTITUDE; POSTOPERATIVE CARE; PRODUCTIVITY; RELAPSE; RISK ASSESSMENT; SIDE EFFECT; TEAMWORK; TREATMENT DURATION; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CROHN DISEASE; GASTROENTEROLOGY; HUMANS; REFERRAL AND CONSULTATION; SURGERY;

EID: 45849083089     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(08)60539-3     Document Type: Article

References (32)

1. AGA Task Force on Quality in practice: a national overview and implications for GI practice. Gastroenterology 129 (2005) 361-369
2. Kennedy A., Nelson E., Reeves D., Richardson G., Roberts C., Robinson A., et al. A randomized controlled trial to assess the effectiveness and cost of a patient oriented self management approach to chronic IBD. Gut 53 (2004) 1639-1645
3. Bassi A., Dodd S., Williamson P., and Bogger K. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 53 (2004) 1471-1478
4. Odes S., Vardi H., Friger M., Wolters F., Russel M., Riis L., et al. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 131 (2006) 719-728
5. Cohen R., Larson L., Roth J., Becker R., and Mummert L. The cost of hospitalization in Crohn's disease. Am J Gastroenterol 95 (2000) 524-530
6. Bernstein C., Waida A., Svenson M., MacKenzie A., Koehoorn M., Jackson M., et al. The epidemiology of Inflammatory Bowel Disease in Canada: a population-base study. Am J Gastroenterol 101 (2006) 1559-1568
7. Vind I., Riis L., Jess T., Knudsen E., Pedersen N., Elkjaer M., et al. Increasing incidences of Inflammatory Bowel Disease and decreasing surgery rates in Copenhagen city and Country, 2003-2005: a population-based study from the Danish Crohn Colitis database. Am J Gastroenterol 101 (2006) 1274-1282
8. Loftus E. Clinical epidemiology of Inflammatory Bowel Disease: incidence, prevalence and environmental influences. Gastroenterol-ogy 126 (2004) 1504-1517
9. Molinie F., Gower-Rousseau C., Yzet T., Merle V., Grandbastien B., Marti R., et al. Opposite evolution in incidence of Crohn's Disease and Ulcerative Colitis in North America. (1988-1999). Gut 53 (2004) 843-848
10. Shivananda S., Lennard-Jones J., Logan R., Fear N., Price A., Carpenter L., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39 (1996) 690-697
11. Card T., Hubbard R., and Logan R. Mortality in inflammatory disease: a population-based cohort study. Gastroenterology 125 (2003) 1583-1590
12. Munkholm P., Langholz E., Davidsen M., Binder V., and Munkholm P. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 30 (1995) 699-706
13. Ekbom A. The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed?. Inflamm Bowel Dis 10 (2004) 32-34
14. Rejler M., Spangeus A., Tholstrup J., and Andersson-Gare B. Improved population-based care: implementing patient-and demand-directed care for Inflammatory Bowel Disease and evaluating the redesign with a population-based registry. Qual Manag Health Care 16 (2007) 38-50
15. Carter M., Labo A., Travis S., and on behalf of the IBD section of the British Society of Gastroenterology. Guidelines for the management of Inflammatory Bowel Disease in adults. Gut 53 (2004) 1-16
16. Windsor A., and Forbes A. Is a multidisciplinary Team essential for the future management of patients with inflammatory bowel disease?. Colorectal Dis 9 (2007) 478-479
17. Nicholls J. The Inflammatory bowel disease unit and multidisci-plinary Team meeting. Colorectal Dis 9 (2007) 477
18. Mayberry J. The diagnosis of Inflammatory Bowel disease- what should we tell to the patient?. Ital J Gastroenterol Hepatol 29 (1997) 483-486
19. Van der Eijk I., Verheggen F., Russel M., Buckley M., Katsanos K., Munkholm P., et al. "Best practice" in inflammatory Bowel disease: an international survey and audit. Eur J Intern Med 15 (2004) 113-120
20. Sands B. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 126 (2004) 1518-1532
21. Parente F., Maconi G., and Bianchi Porro G. Bowel ultrasound in Crohn disease: current role and future applications. Scand J Gastroenterol 37 (2002) 871-876
22. Maconi G., Sampietro G., Parente F., Pompili G., Russo A., Cristaldi M., et al. Contrast radiology, computed tomography and ultrasonog-raphy in detecting internal fistulas and intra-abdominal abscesses in Crohn's disease: a prospective comparative study. Am J Gastroen-terol 98 (2003) 1545-1555
23. Eaden J., and Mayberry J. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patienst with inflammatory bowel disease. Gut 51 (2002) V10-V12
24. Ullman T., Croog V., Harpaz N., Sachar D., and Itzkowitz S. Progression of flat low grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125 (2003) 1311-1319
25. Jenkins D., Balsitis M., Gallivan S., Dixon M., Gilmour H., Shepherd N., et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Iniative. J Clin Pathol 50 (1997) 93-105
26. Su C., Judge T., and Lichtenstein G. Extraintestinal manifestations of inflammatory bowel disease. Gastroenteral Clin North Am 31 (2002) 307-321
27. Danese S., Semeraro S., Papa A., Roberto I., Scaldaferri F., Fedeli G., et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 14 (2005) 7227-7236 11
28. Shorthouse A. Abdominal surgery for Crohn's disease. Coloproctology 2 (2000) 55-62
29. Goodfellow P., Wakefield S., Andersen J., and Shorthouse A. Predicting ileoanal pouch function. Coloproctology 2 (2000) 68-71
30. Fazio V., Ziv Y., Church J., Oakley J., Lavery I., Milsom J., et al. Ileal anal-pouch anastomoses complications and function in 1005 patients. Ann Surg 222 (1995) 120-127
31. Makowiec F., Jehle E., and Starlinger M. Clinical course of perianal Crohn's disease. Gut 37 (1996) 696-701
32. Stebbing J., Jewell D., Keltewell M., and Mortensen N. Long term results of recurrence and reoperation after strictureplasty for obstructive Crohn's disease. Br J Surg 82 (1995) 1471-1474